Drug Abuse Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global drug abuse testing market size reached US$ 6.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.81% during 2022-2028.
Drug abuse is the deliberate consumption of illegal substances or overindulgence of prescribed psychoactive or performance-enhancing chemicals and over-the-counter (OTC) medications. It can affect the mind and body and lead to various disorders like addiction. As a result, it is diagnosed among individuals using different testing methods to provide effective treatment for related disorders. Drug abuse testing also assists in managing acute mental status and seizure cases in the emergency room and identifying children and newborns at risk of exposure to illicit drugs. Nowadays, it finds application in workplaces before hiring an applicant.
Drug Abuse Testing Market Trends:
Presently, drugs like opiates, cannabinoids, cocaine, lysergic acid diethylamide (LSD), barbiturates, amphetamines, alcohol, diazepam, and ketamine are abused for their mind-altering characteristics, non-therapeutic and medicinal uses, and other purposes, including weight loss and enhancing athletic performance. This can lead to drug dependence and substance use disorder, which represents one of the key factors driving the demand for drug abuse testing across the globe. Apart from this, drug abuse can create significant safety and health hazards and decrease the productivity and morale of an individual. This, in turn, is positively influencing the use of drug abuse testing to screen employees and job applicants, provide a safe workplace, and comply with strict government laws and regulations. Moreover, substantial growth in pain management and opioid dependency clinics is catalyzing the demand for urine drug testing worldwide. Furthermore, leading companies are offering automated testing and analysis for drugs of abuse. These companies are also offering at-home use kits for instant drug abuse tests. This, along with the thriving e-commerce industry, is impelling the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global drug abuse testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, sample and end user.
Breakup by Product:
Analyzers
Immunoassays Analyzers
Chromatographic Devices
Breath Analyzers
Rapid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Consumables
Laboratory Services
Breakup by Sample:
Urine
Oral Fluid (Saliva)
Hair
Breath
Others
Breakup by End User:
Hospitals
Diagnostic Laboratories
Forensic Laboratories
Workplaces
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings, Omega Laboratories Inc., Quest Diagnostics Incorporated, Siemens AG, Thermo Fisher Scientific Inc. and United States Drug Testing Laboratories Inc.
Key Questions Answered in This Report:
How has the global drug abuse testing market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global drug abuse testing market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the sample?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global drug abuse testing market and who are the key players?
What is the degree of competition in the industry?